Lithotripsy Clinical Trials

Clinical trials related to Lithotripsy Procedure

Observational Approach Versus Surgical Intervention for Stones

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Procedure, Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The aims of the Observational Approach versus Surgical Intervention for Asymptomatic Stone (OASIS) trial are: 1) to determine whether observation compared to upfront surgery results in less healthcare-related life disruption due to kidney stones among children and adults with asymptomatic kidney stones; 2) to identify the groups benefiting the most from each strategy; and 3) to determine the preferences and values informing the choice between observation and upfront surgery.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 6
Healthy Volunteers: f
View:

• Individuals age 6 or older

• Diagnosis of kidney stone disease (nephrolithiasis)

• Asymptomatic, non-obstructive kidney stones measuring 4 to 10 mm (inclusive)

‣ Asymptomatic is defined as the absence of abdominal pain, flank pain, gross hematuria, and nausea and/or vomiting in the last 3 months that in the judgement of the site PI could be attributable to kidney stones.

⁃ Non-obstructive is defined as a stone in a renal calyx or stones in multiple renal calyces on CT, ultrasound, and/or x-ray obtained within 6 months of screening.

• Informed consent and if appropriate, child assent.

• Willingness to be randomized to surgery or observation Note: subjects otherwise eligible who decline randomization may be enrolled in a parallel observational cohort.

• Fluent in English or Spanish

• Willingness to be audio- and/or video- recorded during interviews

Locations
United States
Minnesota
University of Minnesota
NOT_YET_RECRUITING
Minneapolis
Pennsylvania
The Children's Hospital of Philadelphia
RECRUITING
Philadelphia
Contact Information
Primary
Rebecca D McCune, BS, MS
mccuner@chop.edu
267-909-6030
Backup
Brian J Augelli, BS
augellib@chop.edu
609-504-4908
Time Frame
Start Date: 2026-08-17
Estimated Completion Date: 2032-10-01
Participants
Target number of participants: 1658
Treatments
Active_comparator: Non-Randomized (Observational)
Active_comparator: Randomized
Sponsors
Leads: Children's Hospital of Philadelphia
Collaborators: Patient-Centered Outcomes Research Institute

This content was sourced from clinicaltrials.gov